Analyst Consensus ?
ConsensusBuy49 ratings
Bullish3367.3%
Neutral1632.7%
Bearish00.0%
FN2 Earnings Intelligence
Edwards Lifesciences Corporation analyst ratings
Edwards Lifesciences Corporation (EW) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$90.82Previous close
$70Low
$100.52Average
$140High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BTIG | Buy | Buy | Maintain | Sep 11, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Leerink Partners | Outperform | Market Perform | Upgrade | Jul 24, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 16, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 15, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 13, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jun 2, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 27, 2026 |
| Canaccord Genuity | Hold | Hold | Maintain | Apr 24, 2026 |
| Baird | Neutral | Neutral | Maintain | Apr 24, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 11, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 11, 2026 |
| Stifel | Buy | Buy | Maintain | Jan 20, 2026 |
| UBS | Neutral | Neutral | Maintain | Jan 12, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Oct 29, 2025 |
| Jefferies | Buy | Hold | Upgrade | Oct 29, 2025 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 8, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 25, 2025 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 15, 2025 |
| B of A Securities | Buy | Neutral | Upgrade | Dec 16, 2024 |
| OTR Global | Positive | Mixed | Upgrade | Mar 26, 2024 |
| Raymond James | Market Perform | Outperform | Downgrade | Feb 6, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Apr 27, 2022 |
| Bernstein | Outperform | Market Perform | Upgrade | Mar 16, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Jan 7, 2022 |
| Atlantic Equities | Neutral | Neutral | Maintain | Apr 15, 2021 |
| CFRA | Buy | Buy | Maintain | Apr 24, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 31, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Dec 9, 2019 |
| Bank of America | Buy | Buy | Maintain | Oct 24, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Sep 23, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 24, 2019 |
| Guggenheim | Neutral | Buy | Downgrade | Oct 2, 2018 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Feb 2, 2018 |
| BTIG Research | Neutral | Buy | Downgrade | Feb 2, 2017 |
| Cowen & Co. | Outperform | Outperform | Maintain | Dec 7, 2016 |
| Northland Securities | Outperform | Market Perform | Upgrade | Nov 8, 2016 |
| Northland Capital Markets | Outperform | Market Perform | Upgrade | Nov 8, 2016 |
| Leerink Swann | Outperform | Outperform | Maintain | Apr 4, 2016 |
| Nomura | Buy | Buy | Maintain | Mar 17, 2016 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Mar 7, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Nov 7, 2014 |
| CRT Capital | Buy | Buy | Maintain | Oct 23, 2014 |
| Wunderlich Securities | Hold | Hold | Maintain | Apr 24, 2013 |
| Wunderlich | Hold | Hold | Maintain | Apr 24, 2013 |
| Lazard | Neutral | Buy | Downgrade | Apr 24, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $90.82. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $104 | $90.56 | +14.5% | Oct 27, 2026 |
| UBS | Analyst unavailable | $110 | $83.04 | +21.1% | Jul 28, 2026 |
| Piper Sandler | Analyst unavailable | $101 | $83.82 | +11.2% | Jul 24, 2026 |
| Leerink Partners | Mike Kratky | $101 | $83.82 | +11.2% | Jul 24, 2026 |
| Truist Financial | Richard Newitter | $95 | $86.78 | +4.6% | Jul 16, 2026 |
| RBC Capital | Analyst unavailable | $110 | $92.02 | +21.1% | Jul 13, 2026 |
| Evercore ISI | Analyst unavailable | $100 | $93.12 | +10.1% | Jul 6, 2026 |
| BTIG | Marie Thibault | $110 | $91.18 | +21.1% | Jun 30, 2026 |
| Barclays | Analyst unavailable | $110 | $84.15 | +21.1% | Apr 27, 2026 |
| Truist Financial | Analyst unavailable | $90 | $83.15 | -0.9% | Apr 24, 2026 |
| Evercore ISI | Vijay Kumar | $93 | $83.12 | +2.4% | Apr 24, 2026 |
| BTIG | Analyst unavailable | $100 | $79.72 | +10.1% | Apr 24, 2026 |
| Canaccord Genuity | William Plovanic | $85 | $79.72 | -6.4% | Apr 24, 2026 |
| Mizuho Securities | Analyst unavailable | $95 | $77.28 | +4.6% | Apr 13, 2026 |
| Truist Financial | Richard Newitter | $89 | $76.85 | -2.0% | Feb 11, 2026 |
| Goldman Sachs | David Roman | $95 | $77.05 | +4.6% | Feb 11, 2026 |
| Piper Sandler | Analyst unavailable | $100 | $77.05 | +10.1% | Feb 11, 2026 |
| UBS | Danielle Antalffy | $94 | $81.62 | +3.5% | Feb 4, 2026 |
| Stifel Nicolaus | Analyst unavailable | $110 | $84.35 | +21.1% | Jan 20, 2026 |
| Piper Sandler | Analyst unavailable | $98 | $84.35 | +7.9% | Jan 20, 2026 |
| UBS | Danielle Antalffy | $95 | $83.58 | +4.6% | Jan 12, 2026 |
| Robert W. Baird | Analyst unavailable | $90 | $83.69 | -0.9% | Jan 12, 2026 |
| Barclays | Analyst unavailable | $104 | $85.13 | +14.5% | Jan 12, 2026 |
| Goldman Sachs | David Roman | $108 | $84.58 | +18.9% | Jan 9, 2026 |
| Stifel Nicolaus | Rick Wise | $105 | $85.85 | +15.6% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $94 | $84.34 | +3.5% | Jan 5, 2026 |
| Wells Fargo | Analyst unavailable | $100 | $84.84 | +10.1% | Dec 18, 2025 |
| Canaccord Genuity | William Plovanic | $87 | $85.32 | -4.2% | Dec 17, 2025 |
| Robert W. Baird | David Rescott | $87 | $83.38 | -4.2% | Dec 16, 2025 |
| Barclays | Analyst unavailable | $103 | $86.19 | +13.4% | Dec 8, 2025 |
| UBS | Analyst unavailable | $92 | $86.58 | +1.3% | Dec 5, 2025 |
| RBC Capital | Shagun Singh | $100 | $87.34 | +10.1% | Dec 5, 2025 |
| Robert W. Baird | David Rescott | $88 | $85.78 | -3.1% | Dec 5, 2025 |
| Canaccord Genuity | William Plovanic | $89 | $85.78 | -2.0% | Dec 5, 2025 |
| Wells Fargo | Larry Biegelsen | $96 | $85.78 | +5.7% | Dec 5, 2025 |
| Stifel Nicolaus | Rick Wise | $100 | $85.78 | +10.1% | Dec 5, 2025 |
| Truist Financial | Richard Newitter | $92 | $85.78 | +1.3% | Dec 5, 2025 |
| BTIG | Marie Thibault | $103 | $85.78 | +13.4% | Dec 4, 2025 |
| Bernstein | Lee Hambright | $90 | $82.45 | -0.9% | Nov 3, 2025 |
| UBS | Analyst unavailable | $90 | $82.45 | -0.9% | Nov 3, 2025 |
| Canaccord Genuity | William Plovanic | $84 | $82.45 | -7.5% | Nov 3, 2025 |
| Raymond James | Jayson Bedford | $96 | $82.45 | +5.7% | Nov 3, 2025 |
| National Bank | Analyst unavailable | $92 | $82.46 | +1.3% | Oct 31, 2025 |
| Goldman Sachs | Analyst unavailable | $104 | $84.48 | +14.5% | Oct 31, 2025 |
| RBC Capital | Analyst unavailable | $95 | $83.29 | +4.6% | Oct 31, 2025 |
| Robert W. Baird | David Rescott | $83 | $83.29 | -8.6% | Oct 31, 2025 |
| Barclays | Analyst unavailable | $99 | $83.48 | +9.0% | Oct 31, 2025 |
| Jefferies | Matthew Taylor | $98 | $82.19 | +7.9% | Oct 29, 2025 |
| Truist Financial | Analyst unavailable | $87 | $83.08 | -4.2% | Oct 28, 2025 |
| Truist Financial | Analyst unavailable | $82 | $80.82 | -9.7% | Oct 27, 2025 |
| Evercore ISI | Analyst unavailable | $88 | $76.56 | -3.1% | Oct 7, 2025 |
| Stifel Nicolaus | Rick Wise | $85 | $74.41 | -6.4% | Sep 22, 2025 |
| Canaccord Genuity | William Plovanic | $75 | $76.04 | -17.4% | Apr 25, 2025 |
| Stifel Nicolaus | Rick Wise | $90 | $71.13 | -0.9% | Jan 29, 2025 |
| Bernstein | Lee Hambright | $74 | $74.15 | -18.5% | Jan 8, 2025 |
| Bernstein | Lee Hambright | $72 | $72.62 | -20.7% | Dec 5, 2024 |
| Truist Financial | Richard Newitter | $78 | $72.64 | -14.1% | Dec 5, 2024 |
| Canaccord Genuity | William Plovanic | $68 | $73.26 | -25.1% | Dec 5, 2024 |
| Goldman Sachs | David Roman | $80 | $68.63 | -11.9% | Oct 30, 2024 |
| Bank of America Securities | Travis Steed | $75 | $68.63 | -17.4% | Oct 30, 2024 |
| Citigroup | Joanne Wuensch | $81 | $69.05 | -10.8% | Oct 28, 2024 |
| Robert W. Baird | David Rescott | $73 | $69.63 | -19.6% | Oct 15, 2024 |
| Morgan Stanley | Patrick Wood | $70 | $68.26 | -22.9% | Oct 11, 2024 |
| Canaccord Genuity | William Plovanic | $66 | $65.49 | -27.3% | Oct 7, 2024 |
| Jefferies | Matthew Taylor | $70 | $67.23 | -22.9% | Sep 18, 2024 |
| Truist Financial | Richard Newitter | $71 | $68.13 | -21.8% | Sep 13, 2024 |
| Barclays | Matt Miksic | $80 | $66.81 | -11.9% | Sep 9, 2024 |
| Wells Fargo | Larry Biegelsen | $80 | $66.81 | -11.9% | Sep 9, 2024 |
| Daiwa | Narumi Nakagiri | $72 | $63.64 | -20.7% | Jul 31, 2024 |
| Citigroup | Joanna Wuensch | $83 | $63.74 | -8.6% | Jul 30, 2024 |
| RBC Capital | Shagun Singh | $85 | $60.58 | -6.4% | Jul 25, 2024 |
| Stifel Nicolaus | Rick Wise | $70 | $86.95 | -22.9% | Jul 25, 2024 |
| Piper Sandler | Adam Maeder | $73 | $86.95 | -19.6% | Jul 25, 2024 |
| Truist Financial | Richard Newitter | $110 | $89.5 | +21.1% | Jul 16, 2024 |
| Goldman Sachs | David Roman | $107 | $87.03 | +17.8% | May 30, 2024 |
| Deutsche Bank | Pito Chickering | $103 | $84.7 | +13.4% | May 14, 2024 |
| RBC Capital | Shagun Singh | $101 | $90.28 | +11.2% | Apr 15, 2024 |
| Mizuho Securities | Anthony Petrone | $105 | $91.51 | +15.6% | Apr 11, 2024 |
| Oppenheimer | Suraj Kalia | $100 | $92.85 | +10.1% | Mar 18, 2024 |
| Canaccord Genuity | Analyst unavailable | $76 | $78.21 | -16.3% | Feb 1, 2023 |
| Truist Financial | Analyst unavailable | $86 | $76.7 | -5.3% | Feb 1, 2023 |
| Morgan Stanley | Analyst unavailable | $95 | $76.32 | +4.6% | Jan 6, 2023 |
| Raymond James | Analyst unavailable | $83 | $75.32 | -8.6% | Dec 13, 2022 |
| Citigroup | Analyst unavailable | $92 | $75.26 | +1.3% | Dec 12, 2022 |
| Stifel Nicolaus | Rick Wise | $75 | $73.85 | -17.4% | Dec 5, 2022 |
| RBC Capital | Analyst unavailable | $105 | $75.98 | +15.6% | Nov 28, 2022 |
| RBC Capital | Shagun Singh Chadha | $118 | $70.87 | +29.9% | Oct 28, 2022 |
| Truist Financial | Richard Newitter | $120 | $100.54 | +32.1% | Jul 30, 2022 |
| Canaccord Genuity | Analyst unavailable | $137 | $111.59 | +50.8% | Apr 27, 2022 |
| Raymond James | Analyst unavailable | $124 | $111.86 | +36.5% | Apr 27, 2022 |
| RBC Capital | Analyst unavailable | $135 | $116.27 | +48.6% | Apr 27, 2022 |
| Leerink Partners | Analyst unavailable | $138 | $116.27 | +51.9% | Apr 27, 2022 |
| Evercore ISI | Vijay Kumar | $126 | $120.36 | +38.7% | Apr 6, 2022 |
| Bank of America Securities | Travis Steed | $130 | $111.98 | +43.1% | Mar 3, 2022 |
| Leerink Partners | Danielle Antalffy | $130 | $101.96 | +43.1% | Jan 27, 2022 |
| Stifel Nicolaus | Rick Wise | $120 | $101.96 | +32.1% | Jan 27, 2022 |
| Morgan Stanley | Cecilia Furlong | $136 | $101.96 | +49.7% | Jan 27, 2022 |
| Deutsche Bank | Pito Chickering | $113 | $108.63 | +24.4% | Jan 26, 2022 |
| Credit Suisse | Matt Miksic | $140 | $122.3 | +54.2% | Jan 7, 2022 |
| J.P. Morgan | Robbie Marcus | $140 | $122.12 | +54.2% | Dec 17, 2021 |
| Oppenheimer | Suraj Kalia | $135 | $120.34 | +48.6% | Dec 9, 2021 |
| Wells Fargo | Larry Biegelsen | $133 | $120.34 | +46.4% | Dec 9, 2021 |
| Cowen & Co. | Josh Jennings | $140 | $120.34 | +54.2% | Dec 9, 2021 |
| Jefferies | Anthony Petrone | $135 | $119.54 | +48.6% | Nov 8, 2021 |
Track every rating change on EW the moment it posts. Free to start.
Start freeGet the EW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.